South Korean device company AIRS Medical has gained CE certification for its artificial intelligence (AI)-powered multi-resonance imaging (MRI) enhancement solution, SwiftMR. 

AIRS Medical received 510(k) clearance from the US Food and Drug Administration (FDA) in October 2023. 

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

SwiftMR utilises deep learning technology to enhance MRI image quality, reducing image scan times by up to 50% and improving productivity without requiring additional scanner upgrades or purchases. 

In the announcement accompanying the certification, CEO of AIRS Medical Hyeseong Lee said: “Our MDR CE certification clearly shows AIRS Medical’s capabilities in product quality and regulatory compliance. Through this certification, we will accelerate our market growth in the European market.” 

According to a report on GlobalData’s Medical Intelligence Center, the AI in medical market was worth $336m in 2022 and is expected to grow at a CAGR of 29.1% to $1.2bn by 2027. 

A Medical Device Network insight highlights that AI-assisted MRI is a key innovation area in AI, improving surgical and exam planning, image reconstruction, image analysis, and supporting clinical decision making. 

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In October last year, VUNO gained FDA clearance for its Med-DeepBrain AI tool that characterises brain structures from MRI scans. The algorithms observe 100 brain regions and provide volumetric data on the structures, cortical thickness, and white matter hyperintensity. The company highlighted that the platform could be used to detect dementia and other neurodegenerative diseases in the early stages because the AI can present quantifiable brain data from the patient that had been compared with a normal population. 

Earlier in 2023, Ezra won FDA 510(k) clearance for its AI technology Ezra Flash, for use in brain imaging. Ezra trained the AI to identify the most important components of an MRI scan that are required to produce a complete and precise image. 

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact